All test subjects regardless of exact test objective or body weight require a priming dose of 50 mL PE012 delivered orally (sweetener or other flavoring may increase ease of application, depending on subject species), followed by an incubation period of 24 hours.
Testing any mutagen-class agent without this priming procedure requires dosages that are inactionable at XEDRA-07's current production rates and the difficulty inherent in PE012 transports.
Testing any mutagen-class agent without this priming procedure requires dosages that are inactionable at XEDRA-07's current production rates and the difficulty inherent in PE012 transports.